Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease

PLoS One. 2019 Apr 18;14(4):e0215648. doi: 10.1371/journal.pone.0215648. eCollection 2019.

Abstract

Mendelian Susceptibility to Mycobacterial Diseases (MSMD) is a primary immunodeficiency disease (PID) characterized by variable susceptibility to weakly virulent mycobacteria (Bacille Calmette-Guerin, BCG) and various intramacrophagic bacteria, fungi, parasites. Mycobacterial disease generally begins in childhood, more rarely during adolescence and adulthood. The pathogenesis of MSMD is the inherited impaired production of interferon gamma (IFN-γ) or inadequate response to it. Autosomal recessive IL12RB1 deficiency is the most common genetic etiology of MSMD. Here we identified three novel compound heterozygous mutations in IL12RB1 gene (c.635G>A, c.765delG; c.632G>C, c.847C>T; c.64G>A, c.1673insGAGCTTCCTGAG) in three Chinese families with MSMD.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asian People
  • China
  • Female
  • Genetic Predisposition to Disease*
  • Heterozygote*
  • Humans
  • Infant
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Male
  • Mycobacterium Infections / genetics*
  • Mycobacterium Infections / immunology
  • Point Mutation*
  • Receptors, Interleukin-12 / genetics*
  • Receptors, Interleukin-12 / immunology

Substances

  • IFNG protein, human
  • IL12RB1 protein, human
  • Receptors, Interleukin-12
  • Interferon-gamma

Grants and funding

This work was supported by The National Natural Science Foundation of China (81000079, 81170165 and 81870959 to X.Z.) and supported by Program for HUST Academic Frontier Youth Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.